WILMINGTON, Del., March 11, 2024 (GLOBE NEWSWIRE) — The U.S. Patent and Trademark Office has issued a patent, US11920140, for the use of CRISPR technologies to edit organellar genomes to NAPIGEN, Inc., a biotechnology company that specializes in mitochondrial and chloroplast genome engineering. Read the full release.
Levine Media Groups has launched the Life Sciences D’n’A podcast, a video podcast that explores data analytics and AI in the life sciences. It is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and […]
Despite a difficult financing environment, the rare disease sector made significant advances with a sharp increase in the approval of new medicines, which included the first CRISPR Cas9 gene editing therapy for sickle cell disease, the first gene therapies for hemophilia A and Duchenne muscular dystrophy, and the first redosable gene therapy for dystrophic epidermolysis […]
VACAVILLE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — The California Biomanufacturing Center said the City of Vacaville awarded it a two-year, $750,000 grant through funding provided under the American Rescue Plan Act of 2021 to retrain displaced workers and provide skilled training for new workers. Read the full release here.
Levine Media Group’s Daniel Levine will moderate a series of master classes on therapeutic modalities during the Global Genes’ 2023 RARE Advocacy Summit at the Sheraton San Deigo Hoel & Marina. The master class will cover small molecules and biologics, RNA therapies, gene therapy and gene editing, and a case study of therapies for spinal […]
You can find older news here.